CLINICAL SIGNS AND MODERN THERAPY OF INFECTIOUS BOTULISM

Main Article Content

Jurayeva Muxabbat Ergashevna
Almardanova Zulhumor Jalilovna

Abstract

Infectious botulism is a severe infectious disease caused by a potent neurotoxin produced by the bacterium Clostridium botulinum. This article provides a thorough scientific analysis of the causes, biological and microbiological basis of botulism, the effects of the toxin on the body, clinical forms, diagnostic methods, and modern therapeutic approaches. The food-borne form of botulism, the way the toxin enters the body, its effects on internal organs and the nervous system, the late onset of clinical symptoms, the complexity of diagnosis, and the effectiveness of treatments are discussed in detail. The article also discusses the work being done to combat botulism in the global health system, modern antitoxins, immunotherapy methods, intensive care techniques, and vaccine projects being developed based on new research. The possibilities of establishing effective control over botulism through clinical trials, health system reports, modern laboratory diagnostic achievements, and preventive and epidemiological strategies are considered.  This article is of practical importance for medical professionals, epidemiologists, hygienists, and microbiologists, expanding knowledge about botulism among infectious diseases and contributing to its early detection and treatment.

Downloads

Download data is not yet available.

Article Details

Section

Articles

How to Cite

CLINICAL SIGNS AND MODERN THERAPY OF INFECTIOUS BOTULISM. (2025). International Bulletin of Medical Sciences and Clinical Research, 5(4), 57-62. https://doi.org/10.37547/

References

World Health Organization (WHO). Botulism: epidemiology and public health response. Geneva, 2022.

Sobel J. Botulism. Clinical Infectious Diseases, 2005; 41(8):1167–1173.

Arnon SS, et al. Botulinum Toxin for Medical and Cosmetic Use. New England Journal of Medicine, 2020; 382: 1889–1899.

Ministry of Health of the Republic of Uzbekistan. Practical recommendations for the prevention of botulism. Tashkent, 2021.

Smith TJ et al. Clostridium botulinum neurotoxin serotypes and molecular variants. Toxicon, 2018; 147:68–75.

Koornhof HJ, Songer JG. Foodborne botulism in developing countries. Microbes and Infection, 2019; 21(3):135–142.

CDC. Botulism Surveillance Summary. Atlanta: Centers for Disease Control and Prevention, 2023.

Sheth AN, et al. International Outbreaks of Botulism Associated with Homemade Foods: Lessons Learned, Journal of Food Protection, 2021; 84(10): 1745–1752.

Kadirova R., Safarova D. Microbiology and Clinic of Infectious Diseases. Tashkent, 2020.

SEOM of the Republic of Uzbekistan. Botulism Case Statistics for the Year, 2024 End-of-Year Reports.

Similar Articles

You may also start an advanced similarity search for this article.